Biotechnology & Life Sciences Global On demand · 24-48h

Global Plant Biotechnology Market Strategic Research Report

Global Plant Biotechnology Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Plant Biotechnology Market
$45.8B2025
8.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: GM Crops, Gene Editing (CRISPR), Tissue Culture

By Application: Marker-Assisted Breeding, Biopesticides & Biostimulants, Biofortification

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Market size 2025
$45.8B
Billion USD
Forecast CAGR
8.4%
2025-2032
Forecast 2032
$80.6B
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

The global plant biotechnology market occupies a foundational position at the intersection of agricultural productivity, food security, and life sciences innovation. Valued at approximately USD 45.8 billion in 2024, the market encompasses a broad spectrum of technologies including genetically modified organisms, gene editing platforms, plant tissue culture, molecular markers, and biopesticide development. Plant biotechnology serves as the primary mechanism through which agrochemical companies, seed producers, and public research institutions address the compounding pressures of population growth, arable land constraints, and climate-induced crop stress. The market's commercial significance extends beyond the farm gate, influencing the strategies of multinational food processors, specialty chemical companies, and sovereign agricultural development programs alike.

Market snapshot

Global Plant Biotechnology Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 8.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$45.8B
2025
Forecast
$80.6B
2032
CAGR
8.4%
2025–2032
リージョン
5
global
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
GM CropsGene Editing (CRISPR)Tissue Culture
By Application
Marker-Assisted BreedingBiopesticides & BiostimulantsBiofortification

Table of contents

Click a chapter to expand
01Executive Summary
  • 1.1 Market Synopsis
  • 1.2 Key Findings
  • 1.3 Strategic Recommendations
02Industry Overview & Forecast
  • 2.1 Market Definition & Scope
  • 2.2 Market Value Forecast, 2025-2032 (Value)
  • 2.3 CAGR Analysis & Confidence Intervals
  • 2.4 Historical Market Review, 2019-2024
  • 2.5 Scenario Analysis (Base, Bull, Bear Cases)
03Market Segmentation by Type
  • 3.1 Market by Type Overview
  • 3.2 Genetically Modified (GM) Crops (Value)
  • 3.3 Gene Editing Technologies — CRISPR/Cas9, TALENs, ZFN (Value)
  • 3.4 Plant Tissue Culture & Micropropagation (Value)
  • 3.5 Molecular Marker-Assisted Breeding (Value)
  • 3.6 Biopesticides & Biostimulants Derived from Plant Biotech (Value)
04Market Segmentation by Application
  • 4.1 Market by Application Overview
  • 4.2 Crop Yield Enhancement & Agronomic Trait Development (Value)
  • 4.3 Herbicide & Pest Resistance Engineering (Value)
  • 4.4 Drought, Salinity & Climate Stress Tolerance (Value)
  • 4.5 Nutritional Biofortification & Quality Improvement (Value)
  • 4.6 Industrial & Pharmaceutical Crop Production (Value)
05Regional Market Forecast
  • 5.1 Regional Revenue Share & CAGR (2024 vs 2032)
  • 5.2 Asia Pacific (Value)
  • 5.3 North America (Value)
  • 5.4 Europe (Value)
  • 5.5 Middle East & Africa
  • 5.6 Latin America
06Country-Level Market Forecast
  • 6.1 Top Countries Overview
  • 6.2 United States
  • 6.3 China
  • 6.4 Brazil
  • 6.5 India
  • 6.6 Canada
  • 6.7 Argentina
07Growth Drivers & Inhibitors
  • 7.1 Accelerating Regulatory Approval of Gene-Edited Crops in Major Agricultural Economies
  • 7.2 Rising Demand for Climate-Resilient Seed Varieties Amid Global Crop Yield Volatility
  • 7.3 Expansion of Private R&D Investment in Precision Breeding and Genomics Platforms
  • 7.4 Market Restraints & Challenges
  • 7.5 Opportunities & White-Space Analysis
08Key Company Profiles
  • 8.1 Bayer AG (Crop Science Division) — Revenue, Strategy, Key Products
  • 8.2 Corteva Agriscience — Revenue, Strategy, Key Products
  • 8.3 Syngenta Group (ChemChina) — Revenue, Strategy, Key Products
  • 8.4 BASF SE (Agricultural Solutions) — Revenue, Strategy, Key Products
  • 8.5 Monsanto (integrated into Bayer) / Independent IP Legacy — Revenue, Strategy, Key Products
  • 8.6 KWS SAAT SE & Co. KGaA — Revenue, Strategy, Key Products
  • 8.7 Limagrain Group — Revenue, Strategy, Key Products
  • 8.8 Evogene Ltd. — Revenue, Strategy, Key Products
  • 8.9 Inari Agriculture — Revenue, Strategy, Key Products
  • 8.10 Calyxt (Cibus) — Revenue, Strategy, Key Products
09Competitive Landscape
  • 9.1 Market Concentration & Competitive Intensity
  • 9.2 Market Share Analysis (2024)
  • 9.3 Competitive Positioning Matrix
  • 9.4 Recent Developments: M&A, Partnerships & Product Launches (2023-2025)
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitute Products
  • 10.5 Competitive Rivalry Intensity
11PESTLE Analysis
  • 11.1 Political Factors
  • 11.2 Economic Factors
  • 11.3 Social & Demographic Factors
  • 11.4 Technological Factors
  • 11.5 Legal & Regulatory Factors
  • 11.6 Environmental Factors
12SWOT Analysis
  • 12.1 Market-Level Strengths
  • 12.2 Market-Level Weaknesses
  • 12.3 Strategic Opportunities
  • 12.4 External Threats
13Future Trends & Outlook
  • 13.1 Mainstreaming of RNA-Based Crop Protection as a Next-Generation Biotech Input
  • 13.2 Convergence of Artificial Intelligence and Genomics in Trait Discovery Pipelines
  • 13.3 Commercial Scale-Up of Nitrogen-Fixation Engineering in Non-Legume Staple Crops
  • 13.4 Long-Term Market Outlook (2033-2035)
  • 13.5 Investment & M&A Activity Outlook

Frequently asked questions

What is the size of the plant biotechnology market?
The global plant biotechnology market was valued at approximately USD 45.8 billion in 2024 and is projected to reach approximately USD 87.4 billion by 2032, driven by accelerating adoption of gene-edited crop varieties and expansion of precision breeding platforms across major agricultural economies.
What is the CAGR of the plant biotechnology market?
The global plant biotechnology market is forecast to grow at a compound annual growth rate (CAGR) of approximately 8.4% over the forecast period from 2025 to 2032.
What is driving growth in the plant biotechnology market?
Three primary forces are propelling market expansion. First, a meaningful shift in regulatory posture across the United States, Japan, and Brazil has accelerated commercial approval timelines for gene-edited crop varieties, shortening the path from discovery to commercialization. Second, climate volatility is intensifying demand for drought-tolerant and heat-resilient seed traits, pushing both public and private institutions to scale investments in stress-tolerance engineering. Third, the convergence of high-throughput genomics with machine learning-based trait prediction is compressing R&D cycles, allowing companies to identify commercially viable genetic modifications in substantially less time than conventional breeding permits.
Who are the leading companies in the plant biotechnology market?
The market is concentrated among a small number of multinational life science and agrochemical companies. Bayer AG's Crop Science division holds the largest commercial footprint, with seed and trait revenues exceeding USD 20 billion annually following its acquisition of Monsanto. Corteva Agriscience, Syngenta Group, and BASF Agricultural Solutions are the other tier-one incumbents. Emerging precision breeding specialists such as Evogene and Inari Agriculture are gaining traction in the technology licensing segment.
Which region dominates the plant biotechnology market?
North America currently holds the largest revenue share in the global plant biotechnology market, accounting for approximately 38% of global value in 2024. This dominance reflects the United States' established regulatory infrastructure for GM and gene-edited crops, the concentration of major R&D headquarters, and high rates of commercial biotech crop adoption across corn, soybean, and cotton production systems. Asia Pacific is the fastest-growing region, led by China's aggressive national investment in agricultural genomics and India's expanding biotech seed pipeline.
What segments are covered in this report?
The report covers segmentation by technology type — including GM crops, gene editing platforms (CRISPR/Cas9, TALENs, ZFN), plant tissue culture and micropropagation, molecular marker-assisted breeding, and biotech-derived biopesticides and biostimulants — as well as by application, spanning crop yield enhancement, herbicide and pest resistance, climate stress tolerance, nutritional biofortification, and industrial and pharmaceutical crop production.
What is the forecast period covered in this report?
This report uses 2024 as its base year. The primary forecast period spans 2025 through 2032, with a historical review covering 2019 to 2024 and a long-term directional outlook extending to 2035.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.